These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12830409)

  • 41. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance.
    Bantar C; Sartori B; Vesco E; Heft C; Saúl M; Salamone F; Oliva ME
    Clin Infect Dis; 2003 Jul; 37(2):180-6. PubMed ID: 12856209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey.
    Erbay A; Bodur H; Akinci E; Colpan A
    J Hosp Infect; 2005 Jan; 59(1):53-61. PubMed ID: 15571854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of a target drug monitoring program on the usage of clindamycin.
    Gin AS; Lipinski LA; Honcharik N
    Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic optimization. An evaluation of patient safety and economic outcomes.
    Fraser GL; Stogsdill P; Dickens JD; Wennberg DE; Smith RP; Prato BS
    Arch Intern Med; 1997 Aug 11-25; 157(15):1689-94. PubMed ID: 9250230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic drug monitoring: improved performance through educational intervention.
    D'Angio RG; Stevenson JG; Lively BT; Morgan JE
    Ther Drug Monit; 1990 Mar; 12(2):173-81. PubMed ID: 2315974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-savings from subsidized pro-active pharmacist interventions.
    Law S; Wu W
    J Pharm Pharm Sci; 2003; 6(1):84-94. PubMed ID: 12753731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A team approach to hospital formulary replacement.
    Lee J; Carlson JA; Chamberlain MA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):239-42. PubMed ID: 7587047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical results and cost due to improved antibiotics policies].
    Patka P; Boxma H
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):348. PubMed ID: 10707751
    [No Abstract]   [Full Text] [Related]  

  • 52. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comprehensive system for antimicrobial monitoring and review using a mandatory antimicrobial ordering sheet.
    Jeffrey LP; Mahoney CD
    Hosp Pharm; 1987 Sep; 22(9):877-83. PubMed ID: 10284204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic use review using the "target drug" method.
    Puckett F; Baars R; Seay K
    Hosp Formul; 1987 May; 22(5):489-91. PubMed ID: 10281733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of total control of antibiotic prescribing by infectious disease specialist on antibiotic consumption and cost.
    Beovic B; Kreft S; Seme K; Cizman M
    J Chemother; 2009 Feb; 21(1):46-51. PubMed ID: 19297272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement in antibiotic use secondary to a small hospital antibiotic review.
    Strahl DA; Wightkin WT
    Hosp Formul; 1985 Mar; 20(3):310-2. PubMed ID: 10270306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a computer-assisted antibiotic-dose monitor.
    Evans RS; Pestotnik SL; Classen DC; Burke JP
    Ann Pharmacother; 1999 Oct; 33(10):1026-31. PubMed ID: 10534212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computer-assisted antimicrobial surveillance in a community teaching hospital.
    Jozefiak ET; Lewicki JE; Kozinn WP
    Am J Health Syst Pharm; 1995 Jul; 52(14):1536-40. PubMed ID: 7552895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations.
    Zhou Y; Ma LY; Zhao X; Tian SH; Sun LY; Cui YM
    J Clin Pharm Ther; 2015 Aug; 40(4):404-8. PubMed ID: 25913640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computer-assisted practitioner-response system for studying the use of cimetidine.
    Schwartz JI; Kennedy TJ
    Am J Hosp Pharm; 1982 Jul; 39(7):1198-201. PubMed ID: 7114066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.